Process optimization and evaluation of novel baicalin solid nanocrystals

References

• XingJChenXZhongDAbsorption and enterohepatic circulation of baicalin in ratsLife Sci200578214014616107266
   PubMed Web of Science ®Google Scholar
• ShenYCChiouWFChouYCChenCFMechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytesEur J Pharmacol20034651–217118112650847
   PubMed Web of Science ®Google Scholar
• TsaiPLTsaiTHPharmacokinetics of baicalin in rats and its interactions with cyclosporin A, quinidine and SKF-525 A: a microdialysis studyPlanta Med200470111069107415549664
   PubMed Web of Science ®Google Scholar
• LiversidgeGGCundyKCParticle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogsInt J Pharm199512519197
   Web of Science ®Google Scholar
• LiversidgeEMLiversidgeGGCooperERNanosizing: a formulation approach for poorly-water-soluble compoundsEur J Pharm Sci200318211312012594003
   PubMed Web of Science ®Google Scholar
• MullerRHJacobsCKayserONanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the futureAdv Drug Deliv Rev200147131911251242
   PubMed Web of Science ®Google Scholar
• LiuZDZhangXHWuHYPreparation and evaluation of solid lipid nanoparticles of BCN for ocular drug delivery system in vitro and in vivoDrug Dev Ind Pharm201137447548121054217
   PubMed Web of Science ®Google Scholar
• ChenYJJiaYJinRXPreparation of BCN flexible nano-liposomesChin J Exp Tradit Med Formula20111714
   Google Scholar
• WangCZhaoXMHaoJFLinJThe process on new technology and novel dosage form to improve the bioavailability of BCNChin Tradit Pat Med2012343545549
   Google Scholar
• KeckCMMüllerRHDrug nanocrystals of poorly soluble drugs produced by high pressure homogenizationEur Pharm Biopharm2006621316
   PubMed Web of Science ®Google Scholar
• GaoLZhangDChenMDrug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery systemJ Nanopart Res2008105845862
   Web of Science ®Google Scholar
• Van EerdenbrughBVercruysseSMartens JohanAMicrocrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions – a case study with itraconazoleEur J Pharm Biopharm200870259059618602992
   PubMed Web of Science ®Google Scholar
• YuePFWangYWanJ[The research progress of preparation methods of solid nanocrystal delivery system.]Yao Xue Xue Bao201247911201127 Chinese23227539
   PubMedGoogle Scholar
• LiXSWangJXShenZGZhangPYChenJFYunJPreparation of uniform prednisolone microcrystals by a controlled microprecipitation methodInt J Pharm20073421–2263217566675
   PubMed Web of Science ®Google Scholar
• RabinowBENanosuspension in drug deliveryNat Rev Drug Discov20043978579615340388
   PubMed Web of Science ®Google Scholar
• Van EerdenbrughBVan den MooterGAugustijnsPTop-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid productsInt J Pharm20083641647518721869
   PubMed Web of Science ®Google Scholar
• PatravaleVBDateAAKulkarniRMNanosuspension: a promising drug delivery strategyJ Pharm Pharmacol200456782784015233860
   PubMed Web of Science ®Google Scholar
• SingareDSMarellaSGowthamrajanKKulkarniGTVooturiRRaoPSOptimization of formulation and process variable of nanosuspension: an industrial perspectiveInt J Pharm20104021–221322020933066
   PubMed Web of Science ®Google Scholar
• El-MalahYNazzalSKhanfarNMD-optimal mixture design: optimization of ternary matrix blends for controlled zero-order drug release from oral dosage formsDrug Dev Ind Pharm200632101207121817090443
   PubMed Web of Science ®Google Scholar
• YuePFYuanHLLiXYYangMZhuWFProcess optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complexInt J Pharm20103871–213914620005937
   PubMed Web of Science ®Google Scholar
• YuePFZhengQWuBProcess optimization by response surface design and characterization study on geniposide pharmacosomesPharm Dev Technol20121719410220919929
   PubMed Web of Science ®Google Scholar
• YuePFYuanHLLiXYYangMZhuWFXiaoXHDevelopment and optimization of intravenous puerarin emulsions formation by a novel complex-phase inversion-homogenization technologyChem Pharm Bull200755111563156817978512
   PubMed Web of Science ®Google Scholar
• MüllerRHGohlaSKeckCMState of the art of nanocrystals – special features, production, nanotoxicology aspects and intracellular deliveryEur J Pharm Biopharm20117811921266197
   PubMed Web of Science ®Google Scholar
• YuePFZhengQLiaoMXZhangZZZhuWFProcess optimization, characterization, and release study in vitro of an intravenous puerarin lipid micropheres loaded with the phospholipid complexJ Dispers Sci Technol201032117
   Web of Science ®Google Scholar
• LiaoZGWangGFLiangXLZhaoGWJiangQYOptimization of microwave-assisted extraction of active components from Yuanhu Zhitong prescriptionSep Purif Technol2008632424433
   Web of Science ®Google Scholar
• ZhengSHDengYHApplication of dynamic light scattering on the evaluation of the particles size and distribution of submicroemulsion for injectionChin J Pharm200533126131
   Google Scholar
• GaoLZhangDRChenMHZhengTTWangSMPreparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancementDrug Dev Ind Pharm200733121332133918097807
   PubMed Web of Science ®Google Scholar
• MauludinRMüllerRHKeckCMKinetic solubility and dissolution velocity of rutin nanocrystalsEur J Pharm Biopharm2009364–5502510
   Google Scholar
• MöschwitzerJMüllerRHSpray coated pellets as carrier system for mucoadhesive drug nanocrystalsEur J Pharm Biopharm200662328228716377161
   PubMed Web of Science ®Google Scholar
• WangYLiuZZhangDDevelopment and in vitro evaluation of deacety mycoepoxydiene nanosuspensionColloids Surf B Biointerfaces201183218919721176876
   PubMed Web of Science ®Google Scholar
• KocbekPBaumgartnerSKristlJPreparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugsInt J Pharm20063121–217918616469459
   PubMed Web of Science ®Google Scholar
• MauludinRMüllerRHKeckCMDevelopment of an oral rutin nanocrystal formulationInt J Pharm20093701–220220919114097
   PubMed Web of Science ®Google Scholar
• XiaDNCuiFDPiaoHZEffect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in ratsPharm Res20102791965197620585842
   PubMed Web of Science ®Google Scholar
• JunghannsJUMüllerRHNanocrystal technology, drug delivery and clinical applicationsInt J Nanomedicine20083329530918990939
   PubMed Web of Science ®Google Scholar
• PuXSunJWangYDevelopment of a chemically stable 10- hydroxycamptothecin nanosuspensionsInt J Pharm2009379116717319505545
   PubMed Web of Science ®Google Scholar
• AkaoTKawabataKYanagisawaEBalicalin, the predominant flavone glucuronide of Scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original formJ Pharm Pharmacol200052121563156811197087
   PubMed Web of Science ®Google Scholar
• HaoJWangFWangXDevelopment and optimization of baicalinloaded solid lipid nanoparticles prepared by coacervation method using central composite designEur J Pharm Sci201247249750522820033
   PubMed Web of Science ®Google Scholar
• JungTKammWBreitenbachAKaiserlingEXiaoJXKisselTBiodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?Eur J Pharm Biopharm200050114716010840198
   PubMed Web of Science ®Google Scholar
• GuoJJYuePFLvJLDevelopment and in vivo/in vitro evaluation of novel herpetrione nanosuspensionInt J Pharm20134411–222723323220096
   PubMed Web of Science ®Google Scholar
• JaniPHalbertGWLangridgeJFlorenceATNanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependencyJ Pharm Pharmacol199042128218261983142
   PubMed Web of Science ®Google Scholar